James Millstein News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Listening about the european equities. Which are also positive right now. Right. I look at it every morning. Its called the cnbc app. Okay. Well say its the cnbc app. But you look at that, and see what time it was this morning. They were already sharply up. I saw 92 in the u. S. So we are off the highs at this point. I dont know. I didnt look at fair value. So you have to check that. But we left at 10 45. This was before 5 00. So at least for the last hour. I was listening to the radio at 4 00 a. M. I shouldnt listen to the radio. Are they experts like we are . No. So youre getting information...

and that's all hitting the tape just by 10:00 eastern. so, we have got a lot to get to. i'm going to send it over to scott in the meantime. scott? >> andrew, thanks so much. in other market headlines, a number of prospective borrowers shelved deals to raise new capital or refinance debt yesterday. suddenly, an uncertain interest rate environment is hitting demand. they are collectively aimed at raising money were postponed. and a number of companies pulled plans to refinance syndicated bank loons. corporate bonds passed a fourth deal with no deals brought to market. the emerging ...

paint business. apollo declined to increase its offer. and finally pfizer and johnson & johnson, bad news are scrapping further studies of an experimental alzheimer disease treatment. this comes after the drug failed to help patients with memory robbing condition in a second high-profile late the agency clinical trial. shares of those companies have been falling after hours on that news. in other corporate news. acer wants microsoft to reconsider its planned venture into the tablet market. they argue microsoft's plans to launch their own surface tablet would be negative for the wor...

new jersey. good morning to you. she has a lot more on the terms of the deal. >> good morning. of course all of this comes after a weekend of none stop negotiations, knight securing that funding that it needed though at a very steep cost to shareholders. as you mentioned earlier a formal deal has yet to be announced. according to reporting by david faber as well as kate kelly this is what we expect. the company will sell $400 million worth of convertible securities. a 2% coupon and a conversion price ever $1.50 a share which is below the closing price on friday. most investors are do...